CALA logo

Calithera Biosciences (CALA) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

02 October 2014

Indexes:

Not included

Description:

Calithera Biosciences (CALA) is a biotechnology company focused on developing innovative cancer therapies. They create drugs that target specific pathways in cancer cells, aiming to improve treatment outcomes for patients. Their research emphasizes precision medicine to provide effective solutions for various types of cancer.

Events Calendar

Earnings

Next earnings date:

Feb 14, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 31, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

June 15, 2022

Analyst ratings

Recent major analysts updates

15 Nov '22 SVB Leerink
Market Perform
15 Nov '22 Ladenburg Thalmann
Neutral
29 Aug '22 HC Wainwright & Co.
Buy
16 Aug '22 SVB Leerink
Outperform
11 May '22 Wells Fargo
Equal-Weight
04 Apr '22 SVB Leerink
Outperform
31 Jan '22 Ladenburg Thalmann
Buy
20 Jan '22 SVB Leerink
Outperform
08 Nov '21 HC Wainwright & Co.
Neutral
05 Nov '21 William Blair
Market Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

FAQ

  • What is the primary business of Calithera Biosciences?
  • What is the ticker symbol for Calithera Biosciences?
  • Does Calithera Biosciences pay dividends?
  • What sector is Calithera Biosciences in?
  • What industry is Calithera Biosciences in?
  • What country is Calithera Biosciences based in?
  • When did Calithera Biosciences go public?
  • Is Calithera Biosciences in the S&P 500?
  • Is Calithera Biosciences in the NASDAQ 100?
  • Is Calithera Biosciences in the Dow Jones?
  • When was Calithera Biosciences's last earnings report?
  • When does Calithera Biosciences report earnings?
  • Should I buy Calithera Biosciences stock now?

What is the primary business of Calithera Biosciences?

Calithera Biosciences (CALA) is a biotechnology company focused on developing innovative cancer therapies. They create drugs that target specific pathways in cancer cells, aiming to improve treatment outcomes for patients. Their research emphasizes precision medicine to provide effective solutions for various types of cancer.

What is the ticker symbol for Calithera Biosciences?

The ticker symbol for Calithera Biosciences is NASDAQ:CALA

Does Calithera Biosciences pay dividends?

No, Calithera Biosciences does not pay dividends

What sector is Calithera Biosciences in?

Calithera Biosciences is in the Healthcare sector

What industry is Calithera Biosciences in?

Calithera Biosciences is in the Biotechnology industry

What country is Calithera Biosciences based in?

Calithera Biosciences is headquartered in United States

When did Calithera Biosciences go public?

Calithera Biosciences's initial public offering (IPO) was on 02 October 2014

Is Calithera Biosciences in the S&P 500?

No, Calithera Biosciences is not included in the S&P 500 index

Is Calithera Biosciences in the NASDAQ 100?

No, Calithera Biosciences is not included in the NASDAQ 100 index

Is Calithera Biosciences in the Dow Jones?

No, Calithera Biosciences is not included in the Dow Jones index

When was Calithera Biosciences's last earnings report?

Calithera Biosciences's most recent earnings report was on 14 November 2024

When does Calithera Biosciences report earnings?

The next expected earnings date for Calithera Biosciences is 14 February 2025

Should I buy Calithera Biosciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions